The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez-Borlado, L.
Right arrow Articles by Carrera, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez-Borlado, L.
Right arrow Articles by Carrera, A. C.
The Journal of Immunology, 2003, 170: 4475-4482.
Copyright © 2003 by The American Association of Immunologists

Phosphatidylinositol 3-Kinase Regulates the CD4/CD8 T Cell Differentiation Ratio1

Luis Rodríguez-Borlado2,*, Domingo F. Barber*, Carmen Hernández*, Miguel A. Rodríguez-Marcos{dagger}, Arsenio Sánchez{ddagger}, Emilio Hirsch§, Matthias Wymann, Carlos Martínez-A.* and Ana C. Carrera3,*

* Department of Immunology and Oncology, Centro Nacional de Biotecnología, and {dagger} Centro de Biología Molecular, Consejo Superior de Investigaciones Cientificas, Universidad Autónoma, Cantoblanco, Madrid, Spain; {ddagger} Hospital Puerta de Hierro, San Martín de Porres, Madrid, Spain; § Department of Genetics, Biology, and Biochemistry, University of Torino, Turin, Italy; and Institute of Biochemistry, University of Fribourg, Fribourg, Switzerland

The signaling pathways that control T cell differentiation have only begun to be elucidated. Using T cell lines, it has been shown that class IA phosphatidylinositol 3-kinase (PI3K), a heterodimer composed of a p85 regulatory and a p110 catalytic subunit, is activated after TCR stimulation. Nonetheless, the contribution of p85/p110 PI3K isoforms in T cell development has not been described. Mice deficient in the other family of class I PI3K, p110{gamma}, which is regulated by G protein-coupled receptors, exhibit reduced thymus size. Here we examine T cell development in p110{gamma}-deficient mice and in mice expressing an activating mutation of the p85 regulatory subunit, p65PI3K, in T cells. We show that p110{gamma}-deficient mice have a partial defect in pre-TCR-dependent differentiation, which is restored after expression of the p65PI3K activating mutation. Genetic alteration of both PI3K isoforms also affects positive selection; p110{gamma} deletion decreased and p65PI3K expression augmented the CD4+/CD8+ differentiation ratio. Finally, data are presented showing that both PI3K isoforms influenced mature thymocyte migration to the periphery. These observations underscore the contribution of PI3K in T cell development, as well as its implication in determining the CD4+/CD8+ T cell differentiation ratio in vivo.




This article has been cited by other articles:


Home page
CirculationHome page
A. Fougerat, S. Gayral, P. Gourdy, A. Schambourg, T. Ruckle, M. K. Schwarz, C. Rommel, E. Hirsch, J.-F. Arnal, J.-P. Salles, et al.
Genetic and Pharmacological Targeting of Phosphoinositide 3-Kinase-{gamma} Reduces Atherosclerosis and Favors Plaque Stability by Modulating Inflammatory Processes
Circulation, March 11, 2008; 117(10): 1310 - 1317.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Ji, F. Rintelen, C. Waltzinger, D. Bertschy Meier, A. Bilancio, W. Pearce, E. Hirsch, M. P. Wymann, T. Ruckle, M. Camps, et al.
Inactivation of PI3K{gamma} and PI3K{delta} distorts T-cell development and causes multiple organ inflammation
Blood, October 15, 2007; 110(8): 2940 - 2947.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Mao, E. G. Tili, M. Dose, M. C. Haks, S. E. Bear, I. Maroulakou, K. Horie, G. A. Gaitanaris, V. Fidanza, T. Ludwig, et al.
Unequal Contribution of Akt Isoforms in the Double-Negative to Double-Positive Thymocyte Transition
J. Immunol., May 1, 2007; 178(9): 5443 - 5453.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. A. Deane, M. G. Kharas, J. S. Oak, L. N. Stiles, J. Luo, T. I. Moore, H. Ji, C. Rommel, L. C. Cantley, T. E. Lane, et al.
T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling
Blood, April 1, 2007; 109(7): 2894 - 2902.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Shiroki, S. Matsuda, T. Doi, M. Fujiwara, Y. Mochizuki, T. Kadowaki, H. Suzuki, and S. Koyasu
The p85{alpha} Regulatory Subunit of Class IA Phosphoinositide 3-Kinase Regulates beta-Selection in Thymocyte Development
J. Immunol., February 1, 2007; 178(3): 1349 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. D Barbee and J. Alberola-Ila
Phosphatidylinositol 3-kinase improves the efficiency of positive selection
Int. Immunol., June 1, 2006; 18(6): 921 - 930.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Swat, V. Montgrain, T. A. Doggett, J. Douangpanya, K. Puri, W. Vermi, and T. G. Diacovo
Essential role of PI3K{delta} and PI3K{gamma} in thymocyte survival
Blood, March 15, 2006; 107(6): 2415 - 2422.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Bilancio, K. Okkenhaug, M. Camps, J. L. Emery, T. Ruckle, C. Rommel, and B. Vanhaesebroeck
Key role of the p110{delta} isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110{delta} function in B cells
Blood, January 15, 2006; 107(2): 642 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. D. Barbee and J. Alberola-Ila
Phosphatidylinositol 3-Kinase Regulates Thymic Exit
J. Immunol., February 1, 2005; 174(3): 1230 - 1238.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.